|
|
|
| Efficacy and Safety of Pembrolizumab Immunotherapy Combined with Lenvatinib Molecular Targeted Therapy in Patients with Advanced Liver Cancer |
| ZHANG Jianping, BIAN Weigang, CHEN Surong, CHEN Yan |
| First-author's address: Department of Oncology, Yancheng NO.1 People's Hospital, Yancheng 224600, China |
|
|
|
|
|
|
Received: 22 October 2024
|
|
|
|
|
|
|
